Lotensin Hct
Product Images NDC 54868-5313

4 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lotensin Hct (NDC 54868-5313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Package Label – 20 mg/12.5 mg Tablets. (4904)

Principal Display Panel – Package Label – 20 mg/12.5 mg Tablets. (4904)
Lotensin HCT 20/12.5 mg tablet bottle label from Physicians Total Care, Inc. The label indicates the active ingredients as benazepril hydrochloride 20 mg and hydrochlorothiazide USP 12.5 mg, with a total of 30 tablets. It includes prescribing cautions, storage instructions, the lot number, and expiration date.*
FDA Label Image

Principal Display Panel – Package Label – 20 mg/25 mg Tablets. (5313)

Principal Display Panel – Package Label – 20 mg/25 mg Tablets. (5313)
Lotensin HCT 20mg/25mg tablets packaging label from Physicians Total Care, Inc. The label indicates the active ingredients benazepril hydrochloride and hydrochlorothiazide with strengths of 20mg and 25mg respectively. The container holds 30 tablets. The label also includes a caution that federal law prohibits dispensing without prescription, along with lot and expiration information, usage directions, and manufacturer details.*
FDA Label Image

Benazepril Hydrochloride Structural Formula. (Lotensin Hct 02)

Benazepril Hydrochloride Structural Formula. (Lotensin Hct 02)
Chemical structure of the active ingredient in Lotensin HCT, depicting the molecular arrangement including a bicyclic ring, side chains, and a hydrochloride group represented as HCl.*
FDA Label Image

Hydrochlorothiazide Structural Formula. (Lotensin Hct 03)

Hydrochlorothiazide Structural Formula. (Lotensin Hct 03)
Chemical structure diagram of the active ingredient in Lotensin HCT. The structure shows a chlorobenzene ring substituted with sulfonamide and related functional groups indicative of the compound's molecular configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.